WASHINGTON—Tuesday, the U.S. Supreme Court granted a stay to a July 2020 decision by U.S. District Judge Theodore Chuang that suspended the Food and Drug Administration’s rule, which among other things, requires a woman to have an in-person visit with a health care provider—such as a doctor, physician’s assistant or nurse practitioner—before undergoing a chemical […]